Global Medical REIT (NYSE:XRN) CEO Mark Okey Decker, Jr. Buys 6,875 Shares of Stock

Global Medical REIT Inc. (NYSE:XRN) CEO Mark Okey Decker, Jr. bought 6,875 shares of the company’s stock in a transaction dated Tuesday, August 11th. The stock was bought at an average cost of $35.92 per share, for a total transaction of $246,950.00. Following the acquisition, the chief executive officer owned 75,199 shares of the company’s stock, valued at approximately $2,701,148.08. This trade represents a 10.06% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Global Medical REIT Price Performance

Global Medical REIT stock opened at $36.52 on Friday. Global Medical REIT Inc. has a 12 month low of $29.05 and a 12 month high of $39.93. The company has a debt-to-equity ratio of 1.68, a current ratio of 0.68 and a quick ratio of 0.68. The business has a 50 day simple moving average of $36.59 and a 200-day simple moving average of $35.80. The stock has a market capitalization of $483.43 million, a PE ratio of 9.82 and a beta of 1.09.

Global Medical REIT (NYSE:XRN) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $4.78 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $3.95. The firm had revenue of $39.75 million for the quarter. Global Medical REIT had a net margin of 36.82% and a return on equity of 13.74%. Equities analysts predict that Global Medical REIT Inc. will post 3.06 earnings per share for the current year.

Key Global Medical REIT News

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: Insiders purchased roughly $2.54 million of shares over August 10–12. CEO Mark Okey Decker, Jr. bought 15,425 shares in three transactions, COO Aaron Robert Roseth acquired 13,500 shares for approximately $495,855, and director Charles Fitzgerald purchased 41,600 shares worth about $1.49 million. The purchases increase management’s financial exposure to the company and may signal confidence in its outlook. SEC insider purchase filing
• Positive Sentiment: The company’s latest quarterly results were substantially above expectations, with earnings per share of $4.78 versus the $0.83 analyst consensus and revenue of $39.75 million. Global Medical REIT also reported a 36.82% net margin and 13.74% return on equity, providing fundamental support for the recent interest in the shares.
• Neutral Sentiment: Analyst sentiment remains mixed. The consensus rating is “Hold,” with two Buy, five Hold and one Sell rating; however, the average price target of $40.25 is above the stock’s recent trading range. Price targets include $42 from Citizens JMP and $38 from Compass Point.
• Neutral Sentiment: A recent article discusses the company’s transition and rebranding to Chiron Real Estate, which could affect how investors interpret the company’s identity and strategy. How Did Chiron Real Estate Emerge From the GMRE Rebrand?
• Negative Sentiment: Global Medical REIT carries elevated leverage, with a debt-to-equity ratio of 1.68, while its quick and current ratios are both 0.68. These figures could limit financial flexibility, particularly if interest rates remain high or property markets weaken.

Hedge Funds Weigh In On Global Medical REIT

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Invesco Ltd. increased its holdings in shares of Global Medical REIT by 30.5% in the 2nd quarter. Invesco Ltd. now owns 1,518,668 shares of the company’s stock valued at $10,524,000 after purchasing an additional 355,355 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Global Medical REIT by 8.6% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,514,954 shares of the company’s stock valued at $10,499,000 after purchasing an additional 119,538 shares during the period. Man Group plc boosted its holdings in Global Medical REIT by 1.7% during the second quarter. Man Group plc now owns 600,943 shares of the company’s stock worth $4,165,000 after buying an additional 10,192 shares in the last quarter. Heartland Advisors Inc. boosted its holdings in Global Medical REIT by 177.4% during the fourth quarter. Heartland Advisors Inc. now owns 423,460 shares of the company’s stock worth $14,288,000 after buying an additional 270,786 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its position in Global Medical REIT by 13.2% during the first quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company’s stock worth $3,400,000 after buying an additional 45,243 shares during the period. 57.52% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently issued reports on XRN shares. Citizens Jmp boosted their price target on shares of Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a research note on Tuesday, May 26th. BMO Capital Markets lifted their price objective on Global Medical REIT from $39.00 to $40.00 and gave the company a “market perform” rating in a report on Monday, July 13th. Wall Street Zen cut Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Weiss Ratings downgraded Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, July 30th. Finally, Compass Point reissued a “neutral” rating and issued a $38.00 price target (down from $50.00) on shares of Global Medical REIT in a report on Thursday, May 7th. Two research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Global Medical REIT currently has a consensus rating of “Hold” and a consensus target price of $40.25.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.